CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. (CASIF) Stock Overview
Explore CASI Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.5M
P/E Ratio
-0.04
EPS (TTM)
$-3.02
ROE
3.58%
CASIF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of CASI Pharmaceuticals, Inc. (CASIF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.04 and a market capitalization of 2.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.